Clinical studies recruiting near Charleroi

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Grand Hôpital de Charleroi · Pfizer · NCT06758401 Assessing the Japet.W+ Lumbar Traction Device in Rehabilitation for Patients With Non-specific Mechanical Low Back Pain
NA · Grand Hôpital de Charleroi · Grand Hôpital de Charleroi · NCT06718348 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Grand Hopital de Charleroi ( Site 0404) · Merck Sharp & Dohme LLC · NCT07216703 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · CHU Charleroi Hopital civil Marie-Curie · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 Effect of IMT in Patients After Acute Exacerbations of COPD
NA · Grand Hopial de Charleroi · KU Leuven · NCT07213128 Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients
Phase 4 · Grand Hôpital de Charleroi · University Hospital, Antwerp · NCT05701241 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Grand Hôpital de Charleroi - · Pfizer · NCT07144280 A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic So
Phase 1/Phase 2 · Grand Hospital de Charleroi · Daiichi Sankyo · NCT06330064 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Grand Hopital de Charleroi - Les Viviers /ID# 234178 · AbbVie · NCT04928846 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 Testing and Evaluating a Psychoeducation Tool and Guidelines for Victims of Violence in Belgian Hospitals.
NA · SOSEnfants Charleroi ASBL · University Hospital, Ghent · NCT06780540 A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of C
Phase 3 · Grand Hopital de Charleroi - Les Viviers /ID# 279336 · AbbVie · NCT07525206 Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation
NA · HUmani CHU Charleroi-Chimay · Insel Gruppe AG, University Hospital Bern · NCT05976685 A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours
NA · Grand Hôpital de Charleroi · Jules Bordet Institute · NCT04109131 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combinati
Phase 2 · Grand Hopital de Charleroi - Les Viviers /ID# 276897 · AbbVie · NCT07155174 Proactive TDM Versus Standard Use of Biologics in Psoriasis
Phase 4 · Grand Hôpital de Charleroi · University Hospital, Ghent · NCT06398106 Treatment of ELectroencephalographic STatus Epilepticus After Cardiopulmonary Resuscitation-2 (TELSTAR-2)
NA · Centre Hospitalier Universitaire Marie Curie · University of Twente · NCT06549426 OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Phase 3 · Clinical Trial Site · Olema Pharmaceuticals, Inc. · NCT06016738 A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)
Phase 3 · Grand Hôpital de Charleroi · Daiichi Sankyo · NCT06174987 Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Phase 3 · Revolution Medicines, Inc. · NCT06881784 Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis
NA · Universitair Ziekenhuis Brussel · NCT07029152 A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.
Phase 3 · Charleroi Grand Hospital (GHDC) - Les Viviers Site · Basilea Pharmaceutica · NCT06925321 The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension
Phase 4 · Ziekenhuis Oost-Limburg · NCT07359599 A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherap
Phase 2/Phase 3 · Grand Hopital de Charleroi - Les Viviers /ID# 277282 · AbbVie · NCT07155187 Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult
Phase 3 · Grand Hôpital de Charleroi · Pfizer · NCT07222800 A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With
Phase 3 · GHdC Site Les Viviers · Hoffmann-La Roche · NCT05894239 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06627647 A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratum
Phase 3 · Pfizer · NCT05623020 Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients
Phase N/A · Grand Hôpital de Charleroi · Cliniques universitaires Saint-Luc- Université Catholique de · NCT02139020

Look up another city

Look up another condition